Orthogon Therapeutics
PrivateLast Round
Follow-on Offering
Apr 17, 2026
Total Funding Raised
$23.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Orthogon Therapeutics is a biotechnology company that develops small molecule antiviral drugs for polyomavirus infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orthogon Therapeutics Comparables
Compare Orthogon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hybridize Therapeutics | 81% | |
| Ipsen | 79% | |
| Asahi Kasei | 74% | |
Orthogon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Apr 17, 2026 | ||||
| VC Round | Dec 10, 2024 | ||||
| VC Round | Jul 24, 2023 | ||||
| Follow-on Offering | Nov 8, 2021 | ||||
| Series A | Mar 8, 2018 |
Orthogon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Healthcare Angels | Follow-on Offering |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 235% MoM, from 651 to 2.2K.
- Apr 17, 2026
$11M raised in follow-on offering.
Orthogon Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orthogon Therapeutics's valuation, stock price, and market status.